Delivery Order SPE2DB24D9238-SPE2DB24FDQFM

Award Date 5/6/24
Potential Completion Date 5/28/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,858.76, is for the delivery of NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,002.83, is for the delivery of NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,146.90, is for the delivery of NEXPLANON 68 MG IMPLANTS, a pharmaceutical contraceptive product, to support the medical supply needs of the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $6,837.40 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a large $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,469.92, is for the delivery of NEXPLANON 68 MG IMPLANTS to meet the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,720.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS to support the medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA). This delivery order is part of a larger indefinite delivery contract (IDC) valued up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,145.90, is for the delivery of NEXPLANON 68 MG IMPLANTS to support the recurring pharmaceutical and medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order for $10,720.35 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,565,910,955 units of the contraceptive implant Nexplanon 68 mg and has an ultimate completion date of October 10, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,720.35, is for the delivery of Nexplanon 68 mg implants with a performance period through July 3, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,943.10 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS and is set to expire on February 4, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the issuance of delivery orders for a...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB24FDQFM
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,720.35 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of military health facilities.

DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products. This contract, which runs through December 31, 2025, complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites. Through this vehicle, DMS Pharmaceutical Group provides a wide array of medications, including both common and specialized pharmaceutical items, to support the diverse medical needs of military personnel and their dependents across various DoD healthcare facilities.

Generated 8/5/24, 9:27 AM